Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces 10th Annual Neuroscience Online Event Showcasing Dynamic Speakers
  • USA - English

The 10th annual virtual event will explore the latest advancements aimed at revolutionizing our understanding of the human brain, as well as advancements to combat neurodegenerative disease, and developments in behavior and psychiatric disorder research


News provided by

Labroots

Mar 03, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Neuroscience Virtual Event, March 10, 2022
Neuroscience Virtual Event, March 10, 2022

YORBA LINDA, Calif., March 3, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is pleased to host and produce Neuroscience2022, marking its 10th year! Join us as we review the latest scientific findings for emerging research, treatments, and therapies through collaborative efforts in the field. Under one roof, neurologists, top scientists, clinicians, leading industry and academia institutions, healthcare professionals and research scholars will assemble globally in an inclusive virtual format to hear from well-renowned experts exploring cutting-edge topics.

This one-day agenda organized by the National Institutes of Health (NIH) BRAIN Initiative team and planning committee members promises to carry forward Labroots' annual tradition of bringing pioneers in neuroscience to the forefront while exchanging new data and innovative approaches via its virtual stage.

Conference highlights at a glance include:

  • Keynote delivery: "Modulation of the CSPG Receptor PTPσ to Enhance Neurorepair," presented by Dr. Marc DePaul, Director of Research, NervGen Pharma describing how PTPσ and CSPGs inhibit functional recovery following nervous system damage and analyze the rationale for NVG-291 and/or PTPσ modulation as a therapeutic intervention in degenerative diseases, followed by lively Q&A attendee participation.
  • Keynote delivery: "Getting Into the Brain: the Ethics of Invasive Human Neuroscience Research," led by Dr. Ashley Feinsinger, Adjunct Professor, Department of Medicine and Philosophy, UCLA providing an overview of the ethical issues in basic human neuroscience research with implanted devices and the unique contextual features that engender them, followed by lively Q&A attendee participation.
  • More than ten talks comprising topics such as Neuroethics, Cognitive/Executive function, Technologies/Approaches/BCI, and Disease will comprise the NIH BRAIN Initiative session: Human Neuroscience and the Cross-Cutting Impact of Scientific Collaboration.

"The nervous system has a similar reaction to tissue damage in both trauma and disease," said keynote speaker Dr. Marc DePaul, Director of Research at NervGen Pharma. "Understanding how this basic response inhibits natural repair mechanisms and provides us with an opportunity to restore function by enhancing neurorestorative processes such as axonal regeneration, remyelination, and plasticity. I am excited to discuss how NervGen's technology modulates the response to CNS injury at Labroots' 10th Annual Neuroscience Virtual Conference."

"This year's NIH Brain Initiative presentations are designed to showcase next-gen technologies and approaches that will provide researchers with the tools they need to ask high-impact questions in human neuroscience and disorders of the human nervous system," said Jim Gnadt, Ph.D., Program Director at theL National Institute of Neurological Disorders and Stroke and the NIH BRAIN Initiative. "Given the intracranial access these technologies require, our keynote presentation will focus on the important neuroethical considerations of this research. In subsequent track presentations, up-and-coming early-career scientists will explore a diverse array of topics including, neuroethics, cognitive and executive functions, technologies and brain computer interfaces, and fundamental disease mechanisms."

Dr. Ashley Feinsinger, Adjunct Assistant Professor, Department of Medicine and Philosophy at UCLA, and keynote speaker for the BRAIN Initiative session commented, "As neurotechnologies, surgical techniques, and invasive treatments advance so do opportunities to study the human brain. Consequently, neuroscientists may find themselves facing multifaceted ethical questions about when and how to make use of these opportunities. These questions which involve our understanding of consent, the social value of research, and our conceptions of disability highlight the benefits of cross-disciplinary collaborations. At this conference, I will explore the major ethical questions that invasive neuroscience research must engage and offer a framework for evaluating current and future research practices. I will also share our groups collaborative approach to these questions. Furthermore, Labroots' virtual platform is a fantastic way for a wide range of scientists to come together and learn from one another—something essential for an interdisciplinary field like neuroethics."

Kicking off the day, a sponsored talk by NanoString Technologies will explain the concept of the Spatial Organ Atlas and how the Whole Transcriptome Atlas works titled, "Spatial Transcriptomic Profiling of Spiny Projection Neurons in the Mouse Striatum," followed by lively Q&A. Moreover, you won't want to miss a live discussion sponsored by LUMINEX, a DiaSorin Company identifying some of the challenges of developing disease-modifying therapeutics for neurodegenerative diseases. Other notable speakers will cover how protein aggregates are utilized to develop novel Alzheimer's and Parkinson's disease models, understanding and addressing increased rates of depression during the COVID-19 pandemic, and can peripheral infections trigger multiple system atrophy, and much more.

Produced on Labroots' robust platform with the capability to connect across all desktop and mobile devices, the online environment encompasses a lobby equipped with a leaderboard and gamification, auditorium featuring live-streaming video webcasts, an interactive poster hall to explore data and engage in live chat conversations, exhibit hall (highlighting the latest array of products and technologies), networking lounge to connect with colleagues, and a social media wall and photo booth for enhanced user engagement, providing a complete educational experience for attendees. By participating and attending this event, Continuing Education credit (1 per presentation) can be earned for a maximum of 40 credits.

To learn more about the event and to register free of cost, click here. Use #LRneuro to follow the conversation online.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.